AAPL335.37+1.74 (+0.52%) ▲|ABBV273.22+6.53 (+2.45%) ▲|ABT98.71+0.55 (+0.56%) ▲|ACN197.16+3.76 (+1.94%) ▲|ADBE232.63-5.49 (-2.31%) ▼|AMAT520.12-10.16 (-1.92%) ▼|AMD644.75-4.68 (-0.72%) ▼|AMGN414.64+12.04 (+2.99%) ▲|AMT165.75+0.97 (+0.59%) ▲|AMZN257.78+1.49 (+0.58%) ▲|AVGO374.74-1.08 (-0.29%) ▼|AXP302.68-1.87 (-0.61%) ▼|BA187.60-2.22 (-1.17%) ▼|BAC53.42-0.68 (-1.25%) ▼|BKNG156.85-0.79 (-0.50%) ▼|BLK1,067.12-12.30 (-1.14%) ▼|BMY60.08+0.49 (+0.82%) ▲|BNY141.93-1.80 (-1.25%) ▼|BRK-B505.64+0.10 (+0.02%) ▲|C126.13-2.40 (-1.86%) ▼|CAT813.66-49.78 (-5.77%) ▼|CL87.81+0.56 (+0.64%) ▲|CMCSA21.05-0.19 (-0.87%) ▼|COF194.44-1.38 (-0.70%) ▼|COP129.09-0.26 (-0.20%) ▼|COST948.39+12.71 (+1.36%) ▲|CRM224.91-0.08 (-0.04%) ▼|CSCO117.76-0.18 (-0.15%) ▼|CVS88.89+2.46 (+2.85%) ▲|CVX205.07-2.51 (-1.21%) ▼|DE661.80-20.99 (-3.07%) ▼|DHR219.03+3.42 (+1.58%) ▲|DIS103.87-0.16 (-0.15%) ▼|DUK116.06+0.40 (+0.35%) ▲|EMR159.55-1.85 (-1.15%) ▼|FDX288.76-0.27 (-0.09%) ▼|GD326.69-4.64 (-1.40%) ▼|GE305.43-3.96 (-1.28%) ▼|GEV996.21-33.01 (-3.21%) ▼|GILD148.42+4.19 (+2.91%) ▲|GM80.98-1.03 (-1.26%) ▼|GOOG342.72-1.87 (-0.54%) ▼|GOOGL345.70-1.98 (-0.57%) ▼|GS878.86-18.32 (-2.04%) ▼|HD284.82-1.88 (-0.65%) ▼|HON208.83-4.04 (-1.90%) ▼|IBM220.13-1.17 (-0.53%) ▼|INTC113.46+0.96 (+0.85%) ▲|INTU295.82+6.01 (+2.07%) ▲|ISRG414.06+9.30 (+2.30%) ▲|JNJ260.57+5.79 (+2.27%) ▲|JPM327.83-3.45 (-1.04%) ▼|KO86.42+0.25 (+0.29%) ▲|LIN487.67-2.28 (-0.47%) ▼|LLY1,202.35+44.86 (+3.88%) ▲|LMT502.59-7.53 (-1.48%) ▼|LOW181.14-2.53 (-1.38%) ▼|LRCX326.98-6.96 (-2.08%) ▼|MA571.77+5.19 (+0.92%) ▲|MCD231.64-0.81 (-0.35%) ▼|MDLZ59.59-0.03 (-0.05%) ▼|MDT86.65-0.44 (-0.51%) ▼|META723.98-14.91 (-2.02%) ▼|MMM162.42-1.22 (-0.75%) ▼|MO69.45+0.90 (+1.31%) ▲|MRK144.04+2.10 (+1.48%) ▲|MS188.03-3.00 (-1.57%) ▼|MSFT527.58-1.72 (-0.33%) ▼|MU1,078.04+32.48 (+3.11%) ▲|NEE77.01-0.87 (-1.12%) ▼|NFLX69.18+0.49 (+0.71%) ▲|NKE34.18-0.43 (-1.24%) ▼|NOW139.17+1.20 (+0.87%) ▲|NVDA237.30-1.94 (-0.81%) ▼|ORCL144.11-0.66 (-0.46%) ▼|PEP124.21-1.51 (-1.20%) ▼|PFE28.12+0.62 (+2.24%) ▲|PG149.22+0.81 (+0.54%) ▲|PLTR192.61+0.54 (+0.28%) ▲|PM192.32+1.92 (+1.01%) ▲|QCOM177.44-3.60 (-1.99%) ▼|RTX181.58-1.71 (-0.93%) ▼|SBUX94.87-1.24 (-1.29%) ▼|SCHW95.44-1.36 (-1.41%) ▼|SO85.25-0.19 (-0.22%) ▼|SPG200.00-1.74 (-0.86%) ▼|T24.73+0.30 (+1.21%) ▲|TMO666.59+10.01 (+1.52%) ▲|TMUS169.27+3.34 (+2.01%) ▲|TSLA375.56-5.13 (-1.35%) ▼|TXN285.73-11.50 (-3.87%) ▼|UBER68.58-0.51 (-0.73%) ▼|UNH376.90+0.58 (+0.15%) ▲|UNP275.72-0.89 (-0.32%) ▼|UPS93.17+0.06 (+0.06%) ▲|USB56.22-1.07 (-1.87%) ▼|V371.64+1.00 (+0.27%) ▲|VZ46.45+0.47 (+1.02%) ▲|WFC80.63-0.88 (-1.08%) ▼|WMT107.98+0.78 (+0.73%) ▲|XOM164.61+0.13 (+0.08%) ▲|AAPL335.37+1.74 (+0.52%) ▲|ABBV273.22+6.53 (+2.45%) ▲|ABT98.71+0.55 (+0.56%) ▲|ACN197.16+3.76 (+1.94%) ▲|ADBE232.63-5.49 (-2.31%) ▼|AMAT520.12-10.16 (-1.92%) ▼|AMD644.75-4.68 (-0.72%) ▼|AMGN414.64+12.04 (+2.99%) ▲|AMT165.75+0.97 (+0.59%) ▲|AMZN257.78+1.49 (+0.58%) ▲|AVGO374.74-1.08 (-0.29%) ▼|AXP302.68-1.87 (-0.61%) ▼|BA187.60-2.22 (-1.17%) ▼|BAC53.42-0.68 (-1.25%) ▼|BKNG156.85-0.79 (-0.50%) ▼|BLK1,067.12-12.30 (-1.14%) ▼|BMY60.08+0.49 (+0.82%) ▲|BNY141.93-1.80 (-1.25%) ▼|BRK-B505.64+0.10 (+0.02%) ▲|C126.13-2.40 (-1.86%) ▼|CAT813.66-49.78 (-5.77%) ▼|CL87.81+0.56 (+0.64%) ▲|CMCSA21.05-0.19 (-0.87%) ▼|COF194.44-1.38 (-0.70%) ▼|COP129.09-0.26 (-0.20%) ▼|COST948.39+12.71 (+1.36%) ▲|CRM224.91-0.08 (-0.04%) ▼|CSCO117.76-0.18 (-0.15%) ▼|CVS88.89+2.46 (+2.85%) ▲|CVX205.07-2.51 (-1.21%) ▼|DE661.80-20.99 (-3.07%) ▼|DHR219.03+3.42 (+1.58%) ▲|DIS103.87-0.16 (-0.15%) ▼|DUK116.06+0.40 (+0.35%) ▲|EMR159.55-1.85 (-1.15%) ▼|FDX288.76-0.27 (-0.09%) ▼|GD326.69-4.64 (-1.40%) ▼|GE305.43-3.96 (-1.28%) ▼|GEV996.21-33.01 (-3.21%) ▼|GILD148.42+4.19 (+2.91%) ▲|GM80.98-1.03 (-1.26%) ▼|GOOG342.72-1.87 (-0.54%) ▼|GOOGL345.70-1.98 (-0.57%) ▼|GS878.86-18.32 (-2.04%) ▼|HD284.82-1.88 (-0.65%) ▼|HON208.83-4.04 (-1.90%) ▼|IBM220.13-1.17 (-0.53%) ▼|INTC113.46+0.96 (+0.85%) ▲|INTU295.82+6.01 (+2.07%) ▲|ISRG414.06+9.30 (+2.30%) ▲|JNJ260.57+5.79 (+2.27%) ▲|JPM327.83-3.45 (-1.04%) ▼|KO86.42+0.25 (+0.29%) ▲|LIN487.67-2.28 (-0.47%) ▼|LLY1,202.35+44.86 (+3.88%) ▲|LMT502.59-7.53 (-1.48%) ▼|LOW181.14-2.53 (-1.38%) ▼|LRCX326.98-6.96 (-2.08%) ▼|MA571.77+5.19 (+0.92%) ▲|MCD231.64-0.81 (-0.35%) ▼|MDLZ59.59-0.03 (-0.05%) ▼|MDT86.65-0.44 (-0.51%) ▼|META723.98-14.91 (-2.02%) ▼|MMM162.42-1.22 (-0.75%) ▼|MO69.45+0.90 (+1.31%) ▲|MRK144.04+2.10 (+1.48%) ▲|MS188.03-3.00 (-1.57%) ▼|MSFT527.58-1.72 (-0.33%) ▼|MU1,078.04+32.48 (+3.11%) ▲|NEE77.01-0.87 (-1.12%) ▼|NFLX69.18+0.49 (+0.71%) ▲|NKE34.18-0.43 (-1.24%) ▼|NOW139.17+1.20 (+0.87%) ▲|NVDA237.30-1.94 (-0.81%) ▼|ORCL144.11-0.66 (-0.46%) ▼|PEP124.21-1.51 (-1.20%) ▼|PFE28.12+0.62 (+2.24%) ▲|PG149.22+0.81 (+0.54%) ▲|PLTR192.61+0.54 (+0.28%) ▲|PM192.32+1.92 (+1.01%) ▲|QCOM177.44-3.60 (-1.99%) ▼|RTX181.58-1.71 (-0.93%) ▼|SBUX94.87-1.24 (-1.29%) ▼|SCHW95.44-1.36 (-1.41%) ▼|SO85.25-0.19 (-0.22%) ▼|SPG200.00-1.74 (-0.86%) ▼|T24.73+0.30 (+1.21%) ▲|TMO666.59+10.01 (+1.52%) ▲|TMUS169.27+3.34 (+2.01%) ▲|TSLA375.56-5.13 (-1.35%) ▼|TXN285.73-11.50 (-3.87%) ▼|UBER68.58-0.51 (-0.73%) ▼|UNH376.90+0.58 (+0.15%) ▲|UNP275.72-0.89 (-0.32%) ▼|UPS93.17+0.06 (+0.06%) ▲|USB56.22-1.07 (-1.87%) ▼|V371.64+1.00 (+0.27%) ▲|VZ46.45+0.47 (+1.02%) ▲|WFC80.63-0.88 (-1.08%) ▼|WMT107.98+0.78 (+0.73%) ▲|XOM164.61+0.13 (+0.08%) ▲|
17 C
New York
Wednesday, October 7, 2026

Tag: company

newssourceFORcompanyinformationcontent1releasesmarket

Basilea initiates phase 3 study with antifungal fosmanogepix in invasive mold infections

Allschwil, Switzerland, July 29, 2025

Weekly progress on share repurchase program to cover share plans and reduce capital

Press Release

Amundi: First half and second quarter 2025 results

Amundi: First half and second quarter 2025 results

Questerre announces definitive agreement to acquire 100% of PX Energy

THIS NEWS RELEASE IS NOT FOR DISSEMINATION OR DISTRIBUTION IN THE UNITED STATES OF AMERICA TO UNITED STATES NEWSWIRE SERVICES OR UNITED STATES PERSONS

Game On! Tencent Cloud’s EdgeOne Hackathon Is Here

Nearly US$20,000 Prize Pool and 100 Exclusive Rewards for Top Developers Participants use Tencent Cloud EdgeOne to develop games; finalists to showdown for a 24-hour hackathon...

QCI Announces Acquisition of VizExplorer, Establishes Itself as A Data Activation Powerhouse and Fuels Growth with Expanded Product Suite

LAS VEGAS, July 28, 2025 (GLOBE NEWSWIRE) -- Quick Custom Intelligence (QCI) is proud to announce its new status as a powerhouse in the casino and resort data activation world, following a strategic acquisition of VizExplorer and sustained global expansion. Armed with the combined strengths of QCI’s cutting-edge Artificial Intelligence platform and VizExplorer’s renowned analytics intellectual property, the company is uniquely positioned to drive unprecedented growth. This development enables QCI to invest heavily in an expanded product offering, delivering deeper and wider solutions for a gaming industry that is rapidly diversifying in scope and needs.

Bragar Eagel & Squire, P.C. Reminds Investors of Class Actions Against Neogen, Alto, RxSight, and Replimune and Encourages Investors to Contact the Firm

NEW YORK, July 28, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Neogen Corporation (NASDAQ:NEOG), Alto Neuroscience, Inc. (NYSE:ANRO), RxSight, Inc. (NASDAQ:RXST), and Replimune Group, Inc. (NASDAQ:REPL). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about each case can be found at the link provided.

Bragar Eagel & Squire, P.C. Urges Investors in XPLR Infrastructure, Centene, Biohaven, or Capricor to Inquire About Their Rights in Class Action Lawsuits

If you purchased or acquired securities in any of the above companies during their class period and would like to discuss your legal rights, call Bragar Eagel & Squire partner Brandon Walker or Marion Passmore directly at (212) 355-4648 
If you purchased or acquired securities in any of the above companies during their class period and would like to discuss your legal rights, call Bragar Eagel & Squire partner Brandon Walker or Marion Passmore directly at (212) 355-4648

Pacific Valley Bancorp Announces Its Second Quarter 2025 Financial Results

SALINAS, Calif., July 28, 2025 /PRNewswire/ -- Pacific Valley Bancorp (OTC Pink: PVBK) announced its unaudited financial results for the second quarter of 2025. Net...

Bragar Eagel & Squire, P.C. Reminds Investors in IRobot (IRBT) of the Class Action Lawsuit and Encourages Investors to Inquire About Their Rights

Bragar Eagel & Squire, P.C. Litigation Attorneys Encourage Investors Who Suffered Losses IRobot (IRBT) To Contact Him Directly To Discuss Their Options

PETCO (WOOF) ALERT: Bragar Eagel & Squire, P.C. Reminds Petco Health and Wellness Investors that a Class Action Lawsuit Has Been Filed and Encourages...

Bragar Eagel & Squire, P.C. Litigation Attorneys Encourage Investors Who Suffered Losses In Petco (WOOF) To Contact Him Directly To Discuss Their Options

FDA Approves Apellis’ EMPAVELI® (pegcetacoplan) as the First C3G and Primary IC-MPGN Treatment for Patients 12 and Older

WALTHAM, Mass., July 28, 2025 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) today announced that the U.S. Food and Drug Administration (FDA) has approved EMPAVELI® (pegcetacoplan) as the first treatment for C3 glomerulopathy (C3G) or primary immune complex membranoproliferative glomerulonephritis (IC-MPGN) in patients 12 years of age and older, to reduce proteinuria. C3G and primary IC-MPGN are rare kidney diseases, affecting 5,000 people in the United States.1

Strength Building: How Strength Training Supplements Help You Build Muscle Mass and Keep Growing Stronger – CrazyBulk

New York City, NY, July 28, 2025 (GLOBE NEWSWIRE) -- Build muscle mass and keep growing stronger with CrazyBulk’s legal strength training supplements. Explore the best stacks for real power gains in 2025
In the evolving world of performance fitness, strength building isn’t just about lifting heavier—it’s about training smarter, fueling properly, and choosing science-backed supplements that support sustainable muscle growth. As more athletes, fitness enthusiasts, and bodybuilders shift away from synthetic enhancers, a natural powerhouse is gaining serious ground: CrazyBulk strength training supplements.

Strength Building: How Strength Training Supplements Help You Build Muscle Mass and Keep Growing Stronger – CrazyBulk

New York City, NY, July 28, 2025 (GLOBE NEWSWIRE) -- Build muscle mass and keep growing stronger with CrazyBulk’s legal strength training supplements. Explore the best stacks for real power gains in 2025
In the evolving world of performance fitness, strength building isn’t just about lifting heavier—it’s about training smarter, fueling properly, and choosing science-backed supplements that support sustainable muscle growth. As more athletes, fitness enthusiasts, and bodybuilders shift away from synthetic enhancers, a natural powerhouse is gaining serious ground: CrazyBulk strength training supplements.

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsCompany

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers